SUMMARY OF 2009 SHORT-TERM INCENTIVE PLAN
On March 3, 2009, the Compensation Committee of the Board of Directors of PharMerica Corporation (the “Corporation”)
adopted the 2009 Short-Term Incentive Program (the “STIP”) under the PharMerica Corporation 2007 Omnibus Incentive Plan,
as amended (the “Omnibus Plan”). The STIP provides for performance-based annual cash awards to the Corporation’s Chief
Executive Officer, executive officers, and certain other officers and employees of the Corporation. The STIP advances the
Corporation’s commitment to performance-based compensation practices by providing participants an opportunity to earn
annual cash bonuses upon achievement of certain pre-established short-term performance objectives.
Eligibility . Officers and employees of the Corporation may receive STIP cash awards as determined by the Board of
Directors or the Compensation Committee.
Performance Cycle . The STIP performance cycle is for the current year, beginning on January 1, 2009 and ending on
December 31, 2009.
Award Targets . The amount of the awards under the STIP are based on individual participant bonus targets. Individual
participant bonus targets are established for each participant by the Compensation Committee, in the case of the Chief
Executive Officer, and by the Chief Executive Officer, for other participants, based upon a determination of the appropriate
bonus target amounts which will enable the Corporation to remain competitive, to retain and recruit top employees, and to align
such employee’s interests with certain strategic initiatives of the Corporation. Individual participant bonus targets range from
5% to 100% of base salary, with targets for the Corporation’s executive officers between 25% and 115% of base salary.
The Compensation Committee established the bonus targets under the STIP for the Corporation’s principal executive
officer, principal financial officer and fiscal 2008 named executive officers as follows: